Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas
Andrea M. Gross, Eva Dombi, Pamela L. Wolters, Andrea Baldwin, Anne Dufek, Kailey Herrera, Staci Martin, Joanne Derdak, Kara S. Heisey, Patricia M. Whitcomb, Seth M. Steinberg, David J. Venzon, Michael J. Fisher, Aerang Kim, Miriam Bornhorst, Brian D. Weiss, Jaishri O. Blakeley, Malcolm A. Smith, Brigitte C. Widemann
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas'. Together they form a unique fingerprint.